Payment overview · 2025
General Payments
$173.13
1 reported records · 1 companies
Healthcare provider profile · identity verified
Yuniet Moya
Allopathic & Osteopathic Physicians|Family Medicine · FORT MYERS, FL · NPI 1134501067
Verified facts
What the public records show
CMS Open Payments records show Yuniet Moya received $173.13 in general payments during 2025 across 1 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $173.13 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $173.13 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $173.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 888 | 250 |
| Atorvastatin Calcium | Atorvastatin Calcium | 759 | 278 |
| Losartan Potassium | Losartan Potassium | 750 | 226 |
| Omeprazole | Omeprazole | 466 | 189 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 463 | 275 |
| Levothyroxine Sodium | Levothyroxine Sodium | 444 | 159 |
| Amlodipine Besylate | Amlodipine Besylate | 403 | 153 |
| Fluticasone Propionate | Fluticasone Propionate | 372 | 210 |
| Lisinopril | Lisinopril | 361 | 122 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 348 | 126 |
| Benzonatate | Benzonatate | 345 | 246 |
| Metformin Hcl | Metformin Hcl | 344 | 124 |
| Famotidine | Famotidine | 306 | 142 |
| Xarelto | Rivaroxaban | 289 | 52 |
| Folic Acid | Folic Acid | 274 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 235 | 96 |
| Metoprolol Tartrate | Metoprolol Tartrate | 217 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 210 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 209 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 207 | 73 |
| Tamsulosin Hcl | Tamsulosin Hcl | 196 | 78 |
| Montelukast Sodium | Montelukast Sodium | 194 | 75 |
| Diclofenac Sodium | Diclofenac Sodium | 193 | 118 |
| Sildenafil Citrate | Sildenafil Citrate | 193 | 54 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 181 | 91 |
| Alendronate Sodium | Alendronate Sodium | 179 | 78 |
| Ammonium Lactate | Ammonium Lactate | 178 | 101 |
| Metformin Hcl Er | Metformin Hcl | 167 | 54 |
| Trazodone Hcl | Trazodone Hcl | 159 | 71 |
| Meloxicam | Meloxicam | 157 | 108 |
| Azithromycin | Azithromycin | 155 | 147 |
| Simvastatin | Simvastatin | 155 | 51 |
| Mirtazapine | Mirtazapine | 152 | 77 |
| Glipizide Er | Glipizide | 151 | 48 |
| Clopidogrel | Clopidogrel Bisulfate | 147 | 58 |
| Tramadol Hcl | Tramadol Hcl | 146 | 60 |
| Glipizide | Glipizide | 142 | 52 |
| Mupirocin | Mupirocin | 138 | 89 |
| Alprazolam | Alprazolam | 132 | 44 |
| Quetiapine Fumarate | Quetiapine Fumarate | 132 | 41 |
| Furosemide | Furosemide | 125 | 56 |
| Lactulose | Lactulose | 125 | 74 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 123 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 116 | 49 |
| Warfarin Sodium | Warfarin Sodium | 114 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 111 | 47 |
| Carvedilol | Carvedilol | 107 | 40 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 105 | 28 |
| Clonazepam | Clonazepam | 103 | 27 |
| Celecoxib | Celecoxib | 98 | 30 |
| Hydrocortisone | Hydrocortisone | 98 | 50 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 97 | 92 |
| Finasteride | Finasteride | 92 | 27 |
| Ibuprofen | Ibuprofen | 91 | 50 |
| Prednisone | Prednisone | 81 | 51 |
| Ondansetron Hcl | Ondansetron Hcl | 80 | 47 |
| Tizanidine Hcl | Tizanidine Hcl | 79 | 61 |
| Eliquis | Apixaban | 78 | 27 |
| Fenofibrate | Fenofibrate | 75 | 28 |
| Temazepam | Temazepam | 75 | 20 |
| Allopurinol | Allopurinol | 74 | 20 |
| Atenolol | Atenolol | 74 | 26 |
| Buspirone Hcl | Buspirone Hcl | 73 | 31 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 69 | 25 |
| Sertraline Hcl | Sertraline Hcl | 67 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 65 | 23 |
| Naproxen | Naproxen | 65 | 39 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 62 | 57 |
| Cephalexin | Cephalexin | 61 | 57 |
| Memantine Hcl | Memantine Hcl | 61 | 22 |
| Donepezil Hcl | Donepezil Hcl | 58 | 26 |
| Entresto | Sacubitril/Valsartan | 58 | 11 |
| Erythromycin | Erythromycin Base | 57 | 35 |
| Loperamide | Loperamide Hcl | 56 | 30 |
| Ketoconazole | Ketoconazole | 53 | 31 |
| Nystatin | Nystatin | 53 | 28 |
| Silver Sulfadiazine | Silver Sulfadiazine | 52 | 31 |
| Ciclopirox | Ciclopirox | 51 | 30 |
| Nyamyc | Nystatin | 49 | 21 |
| Baclofen | Baclofen | 47 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 46 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 46 | 16 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 45 | 14 |
| Mometasone Furoate | Mometasone Furoate | 45 | 27 |
| Pioglitazone Hcl | Pioglitazone Hcl | 45 | 11 |
| Lorazepam | Lorazepam | 44 | 14 |
| Alogliptin | Alogliptin Benzoate | 43 | 15 |
| Candesartan Cilexetil | Candesartan Cilexetil | 43 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 18 |
| Latanoprost | Latanoprost | 43 | 11 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 42 | 21 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 41 | 37 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 41 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 39 | 18 |
| Acyclovir | Acyclovir | 37 | 24 |
| Azelastine Hcl | Azelastine Hcl | 37 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 37 | suppressed |
| Pregabalin | Pregabalin | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 35 | 13 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 35 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 11 |
| Irbesartan | Irbesartan | 33 | 13 |
| Pentoxifylline | Pentoxifylline | 33 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 30 | 14 |
| Gavilyte-G | Peg3350/Sod Sulf,bicarb,cl/Kcl | 30 | 30 |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 30 | 27 |
| Amiodarone Hcl | Amiodarone Hcl | 29 | 14 |
| Nifedipine Er | Nifedipine | 29 | 14 |
| Bicalutamide | Bicalutamide | 28 | suppressed |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 27 | 13 |
| Glimepiride | Glimepiride | 27 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | 12 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 26 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 25 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 24 | 11 |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Methimazole | Methimazole | 23 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 22 | 11 |
| Potassium Chloride | Potassium Chloride | 22 | 11 |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 22 | 12 |
| Amoxicillin | Amoxicillin | 21 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 21 | suppressed |
| Lovastatin | Lovastatin | 21 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 20 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Jardiance | Empagliflozin | 20 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 20 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 20 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 17 | 17 |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Tradjenta | Linagliptin | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Lidocaine | Lidocaine | 16 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 16 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 14 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | 13 |
| Glyxambi | Empagliflozin/Linagliptin | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Comfort Ez Insulin Syringe | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Comfort Ez Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Insulin Glargine Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 11 | suppressed |
| Spironolactone | Spironolactone | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $173.13 · 1 records | Boston Scientific Corporation | WATCHMAN FLX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error